Male vs Female Pattern Hair Loss: Why They Look So Different

Androgenetic alopecia is the same condition in both sexes in one narrow sense: dihydrotestosterone, or DHT, binds to receptors in genetically susceptible follicles and progressively miniaturises them. But the pattern of loss, where it starts, how fast it moves, and how complete it becomes, is shaped by a combination of androgen receptor density, follicle sensitivity, and the hormonal environment that surrounds those follicles. That environment is fundamentally different in a male body and a female body, which is why the two patterns look almost nothing alike.

In men, DHT levels are high and relatively stable after puberty. Follicles at the frontotemporal hairline and at the vertex, the crown, carry the densest concentration of androgen receptors. These follicles are genetically primed to respond to DHT by shortening their growth phase, producing progressively finer and shorter hairs until the follicle stops producing a visible shaft entirely. The occipital zone, the back and sides of the scalp, has far fewer androgen receptors, which is why that hair persists even in advanced loss. The Hamilton-Norwood scale maps this progression in seven stages, from a barely perceptible temple recession to near-complete loss across the top with only a horseshoe of hair remaining at the sides and back. Progression is not guaranteed to reach any particular stage; genetics, age of onset, and individual receptor sensitivity all influence how far it goes.

In women, circulating androgens are present but at much lower concentrations, and the enzyme aromatase, more active in female scalp tissue, converts some of those androgens into oestrogen, which is protective for follicles. This does not eliminate androgenetic alopecia in women; it changes its shape. Rather than a receding frontal hairline, women typically experience diffuse thinning across the top and crown, with the frontal hairline often preserved. The Ludwig scale grades this in three stages, from a widening central part to significant thinning visible across the top of the scalp. The reason the frontal hairline holds is partly hormonal protection and partly a different distribution of androgen-sensitive follicles compared to the male scalp. A complete bald patch of the kind seen in men is uncommon in women with androgenetic alopecia alone, though it does occur.

The distinction is not always clean. Women with polycystic ovary syndrome, congenital adrenal hyperplasia, or other conditions that elevate androgen levels can develop a more male-type pattern, including some frontal recession. Post-menopausal women, whose oestrogen levels fall significantly, may find that a pattern they barely noticed in their thirties accelerates noticeably in their fifties. Men with certain hormonal conditions can show a more diffuse pattern. This is why a dermatologist assessing hair loss in a woman does not simply look at where the thinning is, they also ask about menstrual regularity, recent weight changes, and other signs that might point to an underlying hormonal driver rather than straightforward androgenetic pattern loss. Treating the pattern without investigating the driver rarely produces lasting results.

The difference in pattern is not cosmetic trivia, it affects which interventions are appropriate and which are not. Minoxidil, available over the counter in topical form, is used in both men and women but at different concentrations and with different expectations; a dermatologist can advise on what is appropriate for a given case. Oral finasteride works by blocking the conversion of testosterone to DHT and is used in men with androgenetic alopecia, but it is not appropriate for women who are pregnant or may become pregnant, and its use in women generally requires careful clinical assessment. Platelet-rich plasma and low-level laser therapy are sometimes used as adjuncts, with variable evidence for each. Hair transplant surgery is an option for some people, but it requires sufficient donor hair at the back and sides, which is why advanced loss in men can limit candidacy, and why the diffuse pattern in women sometimes makes transplant planning more complex. No intervention reverses follicle death in a follicle that has completely stopped producing hair; the goal is to slow miniaturisation in follicles that are still active. The earlier a pattern is identified and assessed, the more options remain on the table.

Discover expert advice and the latest updates in Skin Care, Hair Care, Wellness, Dermatology, and more at Stay Young guide to lasting beauty and holistic health!